本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioVie Inc

2.04
-0.0991-4.63%
成交量:82.39萬
成交額:164.15萬
市值:1,724.79萬
市盈率:-0.67
高:2.11
開:2.00
低:1.93
收:2.14
52周最高:3.79
52周最低:0.8200
股本:845.11萬
流通股本:840.98萬
量比:0.04
換手率:9.80%
股息:- -
股息率:- -
每股收益(TTM):-3.0500
每股收益(LYR):-3.0500
淨資產收益率:-150.76%
總資產收益率:-79.06%
市淨率:1.68
市盈率(LYR):-0.67

資料載入中...

2026/08/20

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/08/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/08/06

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/08/06

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/08/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/31

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/07/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/12

重要事件披露

Form 8-K - Current report
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/08/11

重要事件披露

Form 8-K - Current report